JSM2026
Back to all people

Jiren Sun

Eli Lilly and Company
1 appearance in the program

Sessions & presentations

Survival Analysis, Count data , Competing Risks & Intercurrent Events
Presentation: Capturing Cumulative Disease Burden in Chronic Kidney Disease Trials Beyond Time-to-First Analysis
Contributed Papers · Sun, Aug 2 , 2:00 PM
Speaker